Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Post-mistake savings require quick wins and steady progress: cut nonessential costs, automate savings, and reassess your priorities.
21,607 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
A new wave of AI-enabled lending could be headed for auto loans. This article explains why upstart's auto loan push m...
A little-known semiconductor company just won EY’s World Entrepreneur of the Year in Monaco, signaling a new era of r...
A respected advisory firm recently trimmed its stake in Peabody Energy, nudging the stock and sparking questions abou...
Pope Leo XIV issues Magnifica Humanitas, framing AI as a modern social contract test that echoes the Industrial Revol...
Tesla’s 2026 year foundational growth centers on ramping four key initiatives that lay the groundwork for the next wa...
Greg Abel’s early moves at Berkshire Hathaway signal a new investment ethos. This analysis breaks down the rationale,...
A top AI analyst argues the AI revolution is still in its early stages, with ASML’s hefty backlog and robust Q1 2026 ...
Solana has faced headwinds, but many investors wonder if solana about have biggest could finally arrive in the second...
Investors chasing solid returns in AI don’t have to chase sky-high premiums. This guide highlights three great value ...
Virgin Galactic stock tumbles on dilution fears tied to a settlement, while AST SpaceMobile and Planet Labs push high...
Chipotle deployed Ava Cado, an AI chatbot, to handle candidate questions, collect basics, schedule interviews, and se...